F. Léger
Impact in
- Transplantation top 5%
- Renal Transplantation Outcomes and Treatments
- Hematology top 10%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
Papers in
-
- Hematopoietic Stem Cell Transplantation 2
- Chronic Myeloid Leukemia Treatments 1
-
- Renal Transplantation Outcomes and Treatments 2
- Co-authors
- Laurent Nguyen (3 shared papers)Christian Puozzo (3 shared papers)Shari S. Lennon (2 shared papers)David E. Fuller (1 shared paper)Pierre P. Marquet (3 shared papers)Annick Rousseau (3 shared papers)Gilles Paintaud (2 shared papers)Yann Le Meur (2 shared papers)
- Journals
- European Journal of Clinical Pharmacology (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)Bone Marrow Transplantation (1 paper)Annals of Oncology (1 paper)Therapeutic Drug Monitoring (1 paper)
- Partner nations
- FranceNetherlandsGermany
In The Last Decade
F. Léger
11 papers receiving 498 citations
Peers
Comparison fields: 5 of 59
- Transplantation 107
- Hematology 149
- Pharmacology 44
- Pharmacology 71
- Oncology 104
Countries citing papers authored by F. Léger
This map shows the geographic impact of F. Léger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Léger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Léger more than expected).
Fields of papers citing papers by F. Léger
This network shows the impact of papers produced by F. Léger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Léger. The network helps show where F. Léger may publish in the future.
Co-authors
The 25 scholars most cited alongside F. Léger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 123 | |
| 2 | 2005 | 97 | |
| 3 | 2004 | 80 | |
| 4 | 2002 | 49 | |
| 5 | 2004 | 37 | |
| 6 | 2004 | 31 | |
| 7 | 2003 | 29 | |
| 8 | 2002 | 25 | |
| 9 | 2009 | 23 | |
| 10 | 2003 | 11 | |
| 11 | 2006 | 7 |
About F. Léger
F. Léger is a scholar working on Hematology, Transplantation, Oncology, Pathology and Forensic Medicine and Pediatrics, Perinatology and Child Health, having authored 11 papers that have together received 512 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (3 papers), Hematopoietic Stem Cell Transplantation (2 papers), Renal Transplantation Outcomes and Treatments (2 papers), Chemotherapy-induced organ toxicity mitigation (2 papers), Childhood Cancer Survivors' Quality of Life (1 paper), Chronic Myeloid Leukemia Treatments (1 paper), Antibiotics Pharmacokinetics and Efficacy (1 paper) and Drug Transport and Resistance Mechanisms (1 paper). The work is most often cited by research in Transplantation (107 citations), Hematology (149 citations), Pharmacology (44 citations), Pharmacology (71 citations) and Oncology (104 citations). F. Léger has collaborated with scholars based in France, Netherlands and Germany. Frequent co-authors include Laurent Nguyen, Christian Puozzo, Shari S. Lennon, David E. Fuller, Pierre P. Marquet, Annick Rousseau, Gilles Paintaud, Yann Le Meur, Étienne Chatelut and Franck Saint‐Marcoux. Their work appears in journals such as European Journal of Clinical Pharmacology, Cancer Chemotherapy and Pharmacology, Bone Marrow Transplantation, Annals of Oncology and Therapeutic Drug Monitoring.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.